FDA issues update on Medtronic’s HeartWare Ventricular Assist Device system

Aug 26, 2022 - 03:35 PM
Image of family in hospital room, smiling

The Food and Drug Administration yesterday provided an update on the HeartWare Ventricular Assist Device system. These updates include new recommendations for patients and providers; information related to FDA’s actions following a June 2022 recall related to battery electrical faults; details on recent recalls conducted by Medtronic including new ways to reduce damage to controller port pins; and information on the system’s pump weld defect.

Related News Articles

Headline
FDA approves first sterilization system for 3D-printed medical devices
The Food and Drug Administration the week of Aug. 7 cleared for marketing the first sterilization system for 3D-printed devices in health care facilities. The…
Headline
EPA proposes new standards for ethylene oxide sterilizing facilities
The Environmental Protection Agency today proposed requiring commercial sterilization facilities to comply within 18 months with stricter emission and…
Headline
FDA releases FAQs on new requirements for medical devices vulnerable to cybersecurity threats
Effective today under the Consolidated Appropriations Act of 2023, medical devices seeking approval from the Food and Drug Administration must meet certain…
Headline
FDA reports issues with certain reworked Philips ventilators
Philips has reported two potential issues with Respironics Trilogy ventilators that were recalled in June 2021 and reworked, the Food and Drug Administration…
Headline
FDA updates EUAs for COVID-19 antigen tests, alerts providers to device recall and shortage
The Food and Drug Administration yesterday revised its emergency use authorizations for all COVID-19 antigen tests to authorize serial testing and require…
Headline
FDA issues update on heart device recall
All hospitals may request a backup controller with modified software for the Heartware Ventricular Assist Device System to use in certain circumstances if the…